The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Amodip 1.25 mg chewable tablets for cats

1.25 mg/tablet Chewable tablet

Ceva Santé AnimaleVPA10815/048/001

Main Information

Trade NameAmodip 1.25 mg chewable tablets for cats
Active SubstancesAmlodipine
Strength1.25 mg/tablet
Dosage FormChewable tablet
Licence HolderCeva Santé Animale
Licence NumberVPA10815/048/001

Group Information

ATC CodeQC08CA01 amlodipine
Therapeutic ClassCardiovascular


Licence Issued23/12/2016
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back